Xencor, Inc. (XNCR): Price and Financial Metrics

XNCR POWR Grades

• Value is the dimension where XNCR ranks best; there it ranks ahead of 42.21% of US stocks.
• The strongest trend for XNCR is in Value, which has been heading down over the past 179 days.
• XNCR ranks lowest in Sentiment; there it ranks in the 8th percentile.

XNCR Stock Summary

• XNCR's price/sales ratio is 17.1; that's higher than the P/S ratio of 93.5% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, XENCOR INC is reporting a growth rate of -227.74%; that's higher than merely 7.28% of US stocks.
• Revenue growth over the past 12 months for XENCOR INC comes in at -69.98%, a number that bests only 3.12% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to XENCOR INC, a group of peers worth examining would be IGMS, DNLI, NTLA, BEAM, and ARVN.
• XNCR's SEC filings can be seen here. And to visit XENCOR INC's official web site, go to www.xencor.com.

XNCR Valuation Summary

• In comparison to the median Healthcare stock, XNCR's price/sales ratio is 247.06% higher, now standing at 17.7.
• Over the past 115 months, XNCR's price/sales ratio has gone down 4.9.

Below are key valuation metrics over time for XNCR.

XNCR Growth Metrics

The 2 year cash and equivalents growth rate now stands at 6.04%.
• The 2 year revenue growth rate now stands at 323.4%.
• The 4 year revenue growth rate now stands at -8.82%.

The table below shows XNCR's growth in key financial areas (numbers in millions of US dollars).

XNCR's Quality Factors

• XNCR has a Quality Grade of D, ranking ahead of 9.2% of graded US stocks.
• XNCR's asset turnover comes in at 0.261 -- ranking 167th of 682 Pharmaceutical Products stocks.
• PTGX, MDWD, and ALBO are the stocks whose asset turnover ratios are most correlated with XNCR.

The table below shows XNCR's key quality metrics over time.